objective. To characterize the degree of colonization with multidrug-resistant organisms (MDROs) among patients admitted to a longterm acute care hospital.
Long-term acute care hospitals (LTACHs) are facilities that admit complex patients after their discharge from acute care hospitals. 1, 2 LTACHs are required by Medicare to have patients with a mean length of stay of 25 days. Qualifying conditions for admission to LTACHs include mechanical-ventilator weaning, long-term intravenous antibiotics, parenteral feeding, and complex wound care. [3] [4] [5] Patients hospitalized at LTACHs have multiple comorbidities, including recent intensive care unit admissions, surgeries, intravenous antibiotics, and long lengths of stay at their acute care hospitals of origin; these characteristics place this population at high risk for carriage of multidrug-resistant organisms (MDROs) on admission to LTACHs. 4, 6 During the past few years, the number of LTACHs in the United States has increased to nearly 400. 7 Some LTACHs have opted to perform surveillance cultures on admission to determine the need for contact isolation. 6 Given the limited data published on colonization of patients at the time of entry to LTACHs, we decided to compile the results of 4 years of surveillance cultures on admission to an urban LTACH.
methods
This retrospective study was performed as part of an infection control initiative at a 70-bed LTACH in the greater Chicago area. This facility is located within 2 floors of an acute care hospital (a hospital within a hospital) and has a full-time infection preventionist. In addition, this institution has ventilator weaning capacity and is continually staffed with respiratory therapists; approximately 25% of all patient-days are ventilator-days. Most rooms are used as single occupancy; however, double-occupancy rooms are available on the basis of the facility's daily census.
Starting in 2005, all patients admitted to this hospital underwent collection of specimens for surveillance cultures within 72 hours of admission. Nursing personnel obtained all specimens and labeled them "MROC" (for multidrugresistant organism culture). Collection sites included the rectum, nares, all wounds, percutaneous gastrostomy tube entry sites, central vascular catheter insertion sites, and skin (axillae and groin); samples of urine and tracheal secretions were also cultured.
This for-profit LTACH contracts with an off-site private laboratory for all its cultures. Briefly, each specimen (regardless of bodily source) labeled as MROC was inoculated in (1) mannitol salt with oxacillin agar plates to determine the presence of methicillin-resistant Staphylococcus aureus (MRSA), (2) bile esculin azide with vancomycin agar plates to select vancomycin-resistant Enterococcus (VRE), and (3) tryptic soy broth with two 30-mg vancomycin discs and four 10-mg tobramycin discs to isolate gram-negative MDROs, including extended-spectrum b-lactamase (ESBL)-producers. Final identification and susceptibility testing were performed using the MicroScan Walkaway System (Siemens Healthcare Diagnostics). As previously described, 8 The term "set of cultures" was used to describe cultures of all specimens collected within 24 hours of each other from a single patient (eg, cultures of specimens from rectal swab samples, nares, and/or wounds). Unique identifiers, assigned by the microbiology laboratory, were used to link individual patients with each set of cultures. The results of cultures of specimens obtained from 24 hours to 30 days after the collection of initial specimens were removed from the analysis; however, results of cultures of specimens from the same patient collected more than 30 days apart were kept in the database. Colonization prevalences were calculated on the basis of the organisms isolated, bodily sites, and year of collection.
Per recommendation of the Infection Control Committee, from January 1 through March 30, 2007, all consecutive patients admitted to the institution underwent collection of rectal swab samples for surveillance culture at 2 weeks after admission; these cultures were performed in addition to cultures of specimens at entry. We present the results of this additional surveillance.
results
From July 28, 2005, through November 1, 2008 (39 months), a total of 1,905 sets of cultures were performed; 166 sets of cultures were removed from the analysis, because the specimens were collected from 24 hours to 30 days after the collection of the patient's original set. A total of 5, 198 individual cultures of specimens from 1,739 patients were analyzed (mean, 2.9 cultures per patient). Of the 5,198 individual cultures, 1,580 (30%) were positive for MDROs, and 947 (54%) of the total 1,739 patients had a culture-positive specimen recovered from any site.
Results by Site Cultured
A total of 1,629 cultures of rectal swab samples were performed over the study period; 807 (50%) were positive for any MDRO, 38% grew VRE, and 9% grew ESBL-producing gram-negative rods (Table) . Among the 807 positive cultures of rectal swab samples, 560 (69%) had only 1 MDRO, 185 (23%) had 2 MDROs, and 62 (8%) had 3 or more MDROs.
Thirty-three percent of 1,518 wound cultures were positive. Among patients who underwent collection of wound specimens for culture, the mean number of wounds tested was 1.5 (range, 1-8). The most frequent organism isolated was VRE (18%), followed by MRSA (7%) and imipenem-resistant A. baumannii (7%). Sixty-five percent of all culture-positive wounds had only 1 MDRO, 28% had 2 MDROs, and 7% had 3 or more different MDROs per culture.
With regard to the 521 cultures of nasal specimens, only 79 (15%) were positive for MDROs. The most common organisms isolated were MRSA (in 6% of such cultures) and VRE (in 4% of such cultures). Interestingly, gram-negative MDROs were identified in 7% of all nasal cultures.
There were 328 specimens from percutaneous gastrostomy tube entry sites cultured, and only 68 (21%) were positive for MDROs. The most common organism isolated was VRE (in 8% of such cultures), followed by ESBL-producing gram-negative rods (in 4% of such cultures). Most specimens from central vascular catheter entry sites (94%) were culturenegative.
Only 49 tracheal aspirates were cultured on admission, and 36 (73%) were negative. Other sources of specimens were urine ( ) and skin ( ); however, the sum of all n p 25 n p 3 these sources was negligible and therefore not analyzed. Rectal swab samples and wound specimens were the most frequent sources of VRE and all MDR gram-negative rods (including imipenem-resistant A. baumannii and imipenem-resistant P. aeruginosa) (Table) .
Concordance between Sites Cultured
Only 923 sets of cultures included cultures of both rectal swab samples and wound specimens; 580 (63%) of these sets had MDROs isolated from any site (eg, rectum, nares, or percutaneous gastrostomy tube entry sites). Among the corresponding 580 colonized patients, 496 (86%) had culturepositive rectal swab samples, but only 361 (62%) had culturepositive wound samples. 
Results by Year of Collection
The percentage of cultures of rectal swab samples found positive for VRE increased from 29% in 2005 to 44% in 2008 ( Figure 1) . Similarly, the percentage of patients carrying ESBL-producing gram-negative rods increased from 8% to 17% throughout the years. To the contrary, imipenem-resistant Acinetobacter rectal colonization stayed constant at approximately 5%. VRE carriage detected via wound cultures increased from 14% in 2005 to 22% in 2008 (Figure 2) . A high prevalence of ESBL-producing gram-negative rods (33%) among wound cultures was observed during 2007, which was followed by 5% in 2008. Imipenem-resistant Acinetobacter wound colonization decreased from 10% in 2005 to 7% in 2008.
Rectal Swab Cultures at 2 Weeks
During the first 3 months of 2007, a total of 86 patients underwent another collection of rectal swab samples at 2 weeks after admission: 39 of these patients had culture-negative rectal swab samples on admission, of whom 15 (38%) had culture-positive rectal swab samples at 2 weeks. Among the 47 patients with culture-positive rectal swab samples on admission, 17 (36%) had acquired a new MDRO on repeat collection.
Readmissions to the Hospital
A total of 60 patients underwent a second collection of specimens for culture more than 30 days after collection of their first set (and thus were counted as new patients for the purposes of this study). Forty-one patients had second collections performed within 6 months (mean, 74.3 days; range, 31-173 days), and 20 had second collections performed after 6 months of their first collection (mean, 364 days; range, 188-614 days). One patient had additional collections during both periods.
These 60 patients had a prevalence of MDRO colonization on initial set of cultures of 35%. The 41 patients with second collections within 6 months had a prevalence of MDRO colonization of 52%, and the 20 patients with second collections after 6 months had a prevalence of MDRO colonization of 32%.
discussion
In this study, we describe the colonization rates among 1,739 patients on admission to an LTACH; more than half of these patients were found to be colonized with MDROs. VRE was the most common organism identified, followed by MDR gram-negative rods, including imipenem-resistant P. aeruginosa and imipenem-resistant A. baumannii. As expected, a subanalysis of patients who had cultures of both rectal swab samples and wounds showed culture of rectal swab samples with the highest yield of MDROs (86% of these patients had culture-positive rectal swab samples, but only 62% had culture-positive wound samples).
The prevalence of MRSA carriage at either nares or other sites remained less than 10%. Furthermore, colonization with either VRE or resistant gram-negative rods was found among all sites cultured, including the nares; this finding suggests that at the time of discharge from acute care hospitals, there is an extensive bioburden of MDROs on patients' skin. Moreover, although gram-negative MDROs were identified in nasal cultures, culturing only nasal specimens would have misled the institution by giving a false low level of colonization.
Surveillance cultures on admission to LTACHs not only identify the extent of multidrug resistance pressure to these institutions but also represent the degree of colonization at the end of acute care hospitalizations; therefore, it is only reasonable to conclude that the degree of colonizationand type of organisms-on admission would differ among LTACHs in different geographical areas, just as it occurs among acute care hospitals. A previous surveillance study performed during hospital stay at a Maryland LTACH showed a predominance of MRSA colonization (28%) and only a 3% imipenem-resistant A. baumannii colonization. 9 The LTACH depicted in our study receives patients discharged from Chicago's tertiary care hospitals and community hospitals from Northwest Indiana. This large geographic area has experienced during the past few years multifacility outbreaks of infection with both OXA-40-producing A. baumannii 10 and KPC-producing enterics. 8 It is interesting to note the high degree of VRE colonization among patients admitted to this LTACH; most likely, this means that VRE is highly endemic in regional acute care hospitals, but we lack the data to confirm this hypothesis.
This study has several limitations, starting with its retrospective nature. Also, nursing personnel had less-than-optimal compliance with collection of specimens for surveillance culture from all bodily sources. Moreover, we lacked dates of admission to the institution, and therefore we assumed collection of specimens was performed within 72 hours of admission (per hospital policy) rather than several days after admission. The latter would give us information on the degree of colonization during hospital stay (representing acquisition within the LTACH) rather than on admission (representing colonization acquired during acute care hospital stays). There were 166 sets of cultures performed on specimens collected from patients within a month of their original sets. Given that we do not have admission dates, we could not determine if these were readmissions or simply overzealous surveillance; therefore, we decided to remove these 166 sets. All MDROs were processed by a private microbiology laboratory rather than a research or academic laboratory; however, results of this private laboratory have been previously validated. 8 In addition, despite the high rate (25%) of mechanical ventilator usage, only 49 patients underwent cultures of tracheal secretions; we suspect this was because of an inappropriate labeling of specimens ("tracheal secretions" rather than "MROC"), as only specimens labeled MROC were collected for this study.
The high degree of colonization with MDROs on admission to LTACHs is important, given that it directly affects regional acute care hospitals. Our 3 main epidemiological questions were as follows: (1) Do patients transferred from acute care hospitals to nearby LTACHs negatively affect LTACH patients' flora because of horizontal transmission of MDROs? (2) Are readmissions of LTACH patients-with long hospital stays, use of mechanical ventilators, and long periods of intravenous antibiotics-to acute care hospitals the cause of further spread of antimicrobial resistance in acute care institutions? (3) Are LTACHs magnifying centers of MDRO carriage because of their patient's acuity and relatively long hospital stay (25 days)? The combination of all 3 scenarios is most likely. We can now say that as many as 50% of patients admitted to LTACHs are already colonized with MDROs. Also, on the basis of our small study performed during 2007, we can also state that patients acquire MDROs during their stays at LTACHs. In addition, a previous study done in the greater Chicago area showed horizontal transmission of KPC-producing gram-negative rods at an LTACH. 11 Furthermore, Stephens et al 12 have also documented the transmission of MDR A. baumannii from an LTACH to an acute care hospital in the Ohio area. The existence of "resistance loops" among acute care hospitals, LTACHs, and nursing homes has been previously postulated 1, 8 ; these "resistance loops" might perpetuate and magnify the number of MDRO carriers by facilitating horizontal transmission among referring and accepting institutions.
On the basis of our data, we recommend screening all patients admitted to LTACHs with cultures of rectal swab samples only, looking for VRE, MRSA, and imipenem-resistant gram-negative rods. The cost of all cultures presented in this study was covered by the institution, and we did not do a cost-benefit analysis of this intervention. It would have been interesting to determine if there was a change in the rate of horizontal transmission of MDROs after universal surveillance was instituted in 2005. Unfortunately, that data is not available. Given that the number of LTACHs is increasing, further research on the epidemiology of MDROs across LTACHs is urgently needed. references
